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Research Article
Endothelial follistatin-like-1 regulates the postnatal
development of the pulmonary vasculature by modulating
BMP/Smad signaling
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Wim Timens4, Quinn D. Gunst3, Luis J. Jimenez-Borreguero5, Martina Schmidt1,
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Abstract
Bone morphogenetic protein (BMP) signaling regulates vascular smooth muscle maturation, endothelial cell proliferation, and tube
formation. The endogenous BMP antagonist Follistatin-like 1 (Fstl1) is highly expressed in pulmonary vascular endothelium of the
developing mouse lung, suggesting a role in pulmonary vascular formation and vascular homeostasis. The aim of this study was to
investigate the role of Fstl1 in the pulmonary vascular endothelium. To this aim, Fstl1 was conditionally deleted from endothelial
and endothelial-derived cells using Tie2-cre driven Fstl1-KO mice (Fstl1-eKO mice). Endothelial-specific Fstl1 deletion was post-
natally lethal, as 70% of Fstl1-eKO mice died at three weeks after birth. Deletion of Fstl1 from endothelium resulted in a
reduction of right ventricular output at three weeks after birth compared with controls. This was associated with pulmonary
vascular remodeling, as the percentage of actin-positive small pulmonary vessels was increased at three weeks in Fstl1-eKO mice
compared with controls. Endothelial deletion of Fstl1 resulted in activation of Smad1/5/8 signaling and increased BMP/Smad-
regulated gene expression of Jagged1, Endoglin, and Gata2 at one week after birth compared with controls. In addition, potent
vasoconstrictor Endothelin-1, the expression of which is driven by Gata2, was increased in expression, both on the mRNA and
protein levels, at one week after birth compared with controls. At three weeks, Jagged1 was reduced in the Fstl1-eKO mice
whereas Endoglin and Endothelin-1 were unchanged. In conclusion, loss of endothelial Fstl1 in the lung is associated with elevated
BMP-regulated genes, impaired small pulmonary vascular remodeling, and decreased right ventricular output.
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Pulmonary vascular development and maturation is a
tightly controlled process that is orchestrated by multiple
signaling pathways, including bone morphogenetic protein
(BMP), which control spatio-temporal gene expression pat-
terns. BMP signaling is important in embryonic vascular
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development and adult vascular homeostasis.1,2 Dysregulation
of BMP signaling has been strongly associated with the
pathogenesis of hereditary vascular diseases, including
familial pulmonary arterial hypertension (PAH), hereditary
hemorrhagic telangiectasia, atherosclerosis, and cerebral
cavernous malformation.3–11 BMP signaling regulates vas-
cular smooth muscle maturation, endothelial cell prolifer-
ation, and tube formation.9,12 Tight spatio-temporal
control of BMP signaling and biological availability is there-
fore crucial for the normal development of vascular struc-
ture and function, including in the lung.
BMP ligands elicit their activity by binding to type I
BMP receptors (ALK1, 2, 3, and 6) and by recruiting type
II BMP receptors (BMPRII, ACVRIIA, and ACVRIIB).
After forming a heterotetrameric complex, the signal propa-
gates to the nucleus by speciﬁcally phosphorylating
the Smad proteins Smad1/5/8. Phosphorylated Smad1/5/8
proteins form a complex with Smad4, which results in accu-
mulation of this complex in the nucleus. This directly and
indirectly inﬂuences transcription of target genes, among
which are Endoglin, Gata2, and Jagged1.13
Follistatin-like 1 (Fstl1) is an endogenous BMP antagon-
ist that is highly expressed in pulmonary vascular endothe-
lium of the developing mouse lung, suggesting a role in
pulmonary vasculature development.14,15 Fstl1 is important
for normal lung development. In fact, multiple organ
defects were observed in whole-body knockout of Fstl1
(Fstl1-KO).15,16 Fstl1-KO mice showed increased thickness
of alveolar walls and increased numbers of immature cuboi-
dal alveolar epithelial cells in the lung.15,16 In addition,
Fstl1-KO mice exhibited impaired tracheal cartilage forma-
tion, alveolar maturation, and lung morphogenesis, result-
ing in respiratory failure and in postnatal lethality in
mice.15,16 Major defects in cardiac and skeletal development
were also reported in Fstl1-KO mice.15,16
Given the complex nature of BMP signaling and the pre-
dominant endothelial expression of the BMP antagonist
Fstl1 in the developing lung, this study aimed to explore
the role of endothelial Fstl1 signaling in pulmonary vascular
development using Tie2-cre mediated endothelial-speciﬁc
deletion of Fstl1 in vivo. Speciﬁcally, we aimed to investi-
gate the impact of Fstl1 deletion on the morphology of the
pulmonary vasculature, on gene expression associated with
BMP signaling, and its implication on pulmonary function.
Methods
Antibodies and reagents
Polyclonal rabbit anti-Fstl1 (#HPA035251), polyclonal
rabbit anti-Jagged1 (#HPA021555), and monoclonal
mouse anti--actin (#A5441) were purchased from Sigma
Aldrich (St. Louis, MO, USA). Polyclonal rabbit anti-a-
smooth muscle actin (a-SMA, #AB5694) and polyclonal
rabbit anti-CD31 (#AB28364) were obtained from Abcam
(Cambridge, UK). Polyclonal goat anti-mouse Endoglin
(#AF1320) was procured from R&D Systems (Oxford,
UK). Polyclonal rabbit anti-phospho-Smad1/5/8
(#AB3848) and monoclonal mouse anti-Troponin I (TnI)
(#MAB16910) were obtained from Millipore (Molsheim,
France) and polyclonal rabbit anti-Smad1 (#9743) from
Cell Signaling (Danvers, MA, USA). Horseradish peroxid-
ase (HRP)-conjugated donkey anti-rabbit IgG (#711-035-
152), donkey anti-goat IgG (#705-035-003), and donkey
anti-mouse IgG (#715-035-150) were purchased from
Jackson Immunoresearch (West Grove, PA, USA). Alexa
Fluor 647 donkey anti-mouse IgG (#A-31571) was obtained
from Thermo Fisher Scientiﬁc (Waltham, MA, USA). All
other chemicals were of analytical grade.
Tie-2cre mediated endothelial-specific deletion of Fstl1
Conditional deletion of Fstl1 from vascular endothelial and
endothelial-derived cells was achieved by crossing ﬂoxed
homozygous Fstl1ﬂ/ﬂ mice with double heterozygous mice
carrying one Fstl1 knockout allele and the Tie2-cre cassette
(Fstl1WT/KO Tie2-cre) on a FVB background.15,17 Within this
cross, endothelial-speciﬁc knockout mice (Fstl1ﬂ/KO Tie2-cre)
and littermate controls (Fstl1ﬂ/WT Tie2-cre, Fstl1ﬂ/KO, and
Fstl1ﬂ/WT) were generated. Fstl1ﬂ/KO Tie2-cre mice are denoted
as Fstl1-eKO and their littermate controls are denoted as
controls. The breeding lines were maintained in the animal
facility of the University of Amsterdam. All experimental
procedures complied with institutional and national ethical
guidelines regarding animal experimentation. Mice were
sacriﬁced at one and three weeks after birth (one week:
n¼ 12 Fstl1-eKO mice and n¼ 16 controls; three weeks:
n¼ 11 Fstl1-eKO mice and n¼ 30 controls). The lung
tissue was collected. Lung lobes (right superior, middle,
and inferior lobes) were inﬂated with 50% Tissue-Tek
(Sakura Finetek; Alphen-aan-den-Rijn, The Netherlands)
in 0.9% NaCl (Braun; Kronberg, Germany) and ﬁxed
with 10% v/v formalin for paraﬃn-embedded sections.
The non-inﬂated lobes (left and post caval lobes) were
snap-frozen in liquid nitrogen for mRNA and protein ana-
lysis. The pups were genotyped using polymerase chain reac-




TGGACAT-3’); cre-recombinase reverse (5’-GCTAGAGC
CTGTTTTGCACGTTCA-3’).
In situ hybridization
In situ hybridization was performed as previously
described.18 In short, lung sections were deparaﬃnized and
rehydrated in a graded series of alcohol, followed by 15min
incubation at 37C in 10mg/mL proteinase K dissolved in
phosphate buﬀered saline (PBS). The sections were post-
ﬁxed for 10min in 4% paraformaldehyde (PFA) and
0.2% glutaraldehyde in PBS, followed by rinsing in PBS.
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Pre-hybridization was done for at least 1 h at 70C in
hybridization mix (50% formamide, 5SSC (20 SSC;
3M NaCl, 0.3M tri-sodium citrate, pH 4.5)), 1% blocking
solution, 5mM EDTA, 0.1% 3-[(3-Cholamidopropyl)
dimethylammonio]-1-propanesulfonate (Sigma Aldrich; St.
Louis, MO, USA), 0.5mg/mL heparin (BD Biosciences;
Erembodegem, Belgium), and 1mg/mL yeast total RNA
(Roche Applied Science; Penzberg, Germany). A digoxi-
genin (DIG)-labeled probe (1 ng/mL) was added to the
hybridization mix. Probes speciﬁc to Fstl1 were used.
After overnight hybridization, the sections were rinsed
with 2SSC, followed by two washings (50% formamide,
2 SSC, pH 4.5) at 65C, and rinsing with TNT (0.1M Tris-
HCl, pH 7.5, 0.15M NaCl, 0.05% Tween-20) at room tem-
perature. The sections were incubated for 1 h in MABT-
block (100mM maleic acid, 150mM NaCl, pH 7.4, 0.05%
Tween-20, 2% blocking solution), followed by 2 h incuba-
tion in MABT-block containing 100 mU/mL alkaline phos-
phatase-conjugated anti-DIG Fab fragments (Sigma
Aldrich; St. Louis, MO, USA). After rinsing in TNT and
subsequently in NTM (100 mM Tris, pH 9.0, 100mM NaCl,
50mM MgCl2), probe binding was visualized using nitro
blue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl-
phosphate (Roche Applied Science; Penzberg, Germany).
The sections were dehydrated in a graded alcohol series,
rinsed in xylene, and embedded in Entellan (Millipore;
Molsheim, France). Images were captured using a Leica
DFC320 camera mounted on an AxioPhot microscope
(Zeiss; Oberkochen, Germany).
Pulmonary physiological measurement
Pulmonary physiological functions were measured in mice
at one week (n¼ 4 Fstl1-eKO mice and n¼ 14 controls) and
three weeks (n¼ 8 Fstl1-eKO mice and n¼ 19 controls) after
birth using transthoracic echocardiography as previously
described.19
RNA isolation and real-time quantitative PCR
Total RNA was extracted from lung tissue (post caval lobe)
using the NucleoSpin RNA isolation kit according to the
manufacturer’s instruction (Macherey Nagel; Du¨ren,
Germany). The total RNA concentration was determined
using the NanoDrop ND1000 spectrophotometer
(Thermo Fisher Scientiﬁc; Waltham, MA, USA). Equal
amounts of total RNA were reverse transcribed using the
Reverse Transcription System (Promega; Madison, WI,
USA) to generate cDNA. Diluted cDNA was mixed with
FastStart Universal SYBR Green Master Mix (Roche
Applied Science; Penzberg, Germany) and gene of interest
primer sets (Biolegio; Nijmegen, The Netherlands). Primer
sequences are listed in Supplementary Table 1. Real-time
quantitative PCR (qPCR) was performed using the
Illumina Eco Personal qPCR System (Westburg; Leusden,
The Netherlands). The qPCR reaction was started by
denaturation at 95C for 15min followed by 45 cycles of
denaturation at 94C for 30 s, annealing at 59C for 30 s,
and elongation at 72C for 30 s. Final elongation was for
5min at 72C. Real-time PCR data were analyzed using
LinRegPCR software version 2013.1.20 Data were expressed
in arbitrary units as ratio of the starting concentration (N0)
of each gene of interest corrected to the geometric mean of
the N0 value of two reference genes (B2m and Hprt).
Comparing the expression levels of the genes of interest
between the three non-conditional knockout groups
(Fstl1ﬂ/WT Tie2-cre, Fstl1KO/ﬂ, or Fstl1WT/ﬂ mice) did not
reveal signiﬁcant diﬀerences, allowing pooling of the data
and using them as age-matched controls.
Western blot
Total protein was extracted from lung tissue (left lobe) using
RIPA lysis buﬀer (RIPA lysis buﬀer 65mM Tris, 155mM
NaCl, 1% Igepal CA-630, 0.25% sodium deoxycholate,
1mM EDTA, pH 7.4) supplemented with protease
inhibitors (1 mg/mL aprotinin, 1 mg/mL leupeptin, 1 mg/mL
pepstatin A, 1mM Na3VO4, 1mM NaF, 1mM -glycero-
phosphate). Equal amounts of protein lysate were subjected
to SDS PAGE electrophoresis and transferred to nitrocellu-
lose or Polyvinylidene diﬂuoride (PVDF) membranes to
evaluate the expression level of non-phosphorylated (-
actin, Jagged1, Endoglin, total Smad1) and phosphorylated
(pSmad1/5/8) proteins, respectively. Proteins of interest were
detected using primary antibodies for overnight at 4C in in
TBST (50mMTris-HCl, 150mMNaCl, 0.05% [w/v] Tween-
20, pH 7.4). The following day, membranes were incubated
with HRP-conjugated secondary antibodies for 2 h at room
temperature. Protein bands were subsequently visualized
using enhanced chemiluminescence substrate (Perkin
Elmer; Groningen, The Netherlands) using the G-box gel
documentation system (Syngene; Cambridge, UK). Protein
band intensities were quantiﬁed using Image Studio Lite ver-
sion 5. Data are presented as ratio of non-phosphorylated
protein band intensity corrected to -actin as a reference
protein. For phosphorylated proteins, data are presented
as ratio of phosphorylated protein corrected to total protein.
Immunostaining
Paraﬃn-embedded lung tissues were sectioned at 5 mm thick-
ness and stained for a-SMA (Abcam; Cambridge, UK),
which was visualized by staining with HRP-conjugated sec-
ondary antibody and diaminobenzidine as a substrate
(Sigma Aldrich; St. Louis, MO, USA). To determine
the actin content in large vessels (>50 mm in diameter),21
the a-SMA staining surrounding muscular and elastic ves-
sels was digitally captured in two lung tissue sections per
animal and quantiﬁed using Image J (National Institute of
Health, USA) in a blinded fashion. Data are expressed
as ratio of the actin-positive area over the square of the
length of the tunica intima. To determine the total number
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of small vessels (<50 mm in diameter),21 CD31 staining was
performed in serial sections to stain for endothelial cells.
Data are expressed as the total number of CD31-positive
small vessels corrected to lung surface area (cm2).
Furthermore, the number of actin-positive small vessels as
well as the total number of CD31-positive small vessels was
quantiﬁed in two lung tissue sections per animal, in a
blinded fashion. Data are expressed as the number of
actin-positive small vessels corrected to the total number
of CD31-positive small vessels. To evaluate muscularization
of the right heart, paraﬃn-embedded heart tissues were sec-
tioned at 10 mm and stained using the myocardial marker
TnI which was visualized by staining with Alexa Fluor 647-
conjugated secondary antibody. The images were digitally
captured in a blinded manner using a ﬂuorescent microscope
(Leica Dm6000; Wetzlar, Germany). The right ventricular
free wall was outlined in each section and the mean ﬂuores-
cence intensity of the outlined structure was measured using
3D Amira software (Version 5.4.3).
Endothelin-1 enzyme-linked immunosorbent
assays (ELISA)
The Endothelin-1 protein concentration in lung homogenates
was determined using ELISA according to the manufacturer’s
protocol (R&D system; Oxford, UK) in duplicate. The sample
absorbance was determined at 450nm and at 570nm to cor-
rect for optical imperfections using Gen5an software using a
plate reader (BioTek; Winooski, VT, USA). The lower and
upper detection limits for Endothelin-1 were 0.39 pg/mL and
25pg/mL, respectively.
Hematoxylin and eosin staining
Paraﬃn-embedded lung tissue sections of 5 mm thick were
deparaﬃnized and rehydrated in a graded series of alcohol,
followed by hematoxylin staining. After washing with ﬂow-
ing water, sections were counterstained with eosin. The sec-
tions were dehydrated in a graded series of alcohol, rinsed in
xylene, and embedded in KP-mounting medium (Klinipath
BV; Duiven, the Netherlands). Images were captured using
Cell^D imaging software using a light microscope (Olympus
BX41; Zoeterwoude, the Netherlands).
Data analysis
Data are presented as medians per genotype-group except
otherwise stated. To determine the normality of data distri-
bution, a Shapiro–Wilk normality test was performed prior
to further statistical analysis. The statistical signiﬁcance of
diﬀerences of normally distributed data was performed
using an independent samples two-tailed t-test for compar-
ing two groups or a two-way ANOVA followed by a post
hoc Tukey multiple comparisons test for comparing more
than two groups. For non-Gaussian distributed data, the
statistical signiﬁcance of diﬀerences was determined using
a non-parametric Mann–Whitney U test for comparing
two groups or non-parametric one-way ANOVA with a
post hoc Kruskal–Wallis multiple comparisons test for com-
paring more than two groups. The Bonferroni correction
was used to correct for multiple testing. Diﬀerences were
considered to be statistically signiﬁcant at P< 0.05.
Results
Loss of Fstl1 from endothelial cells is postnatally
lethal in mice
We and others have previously demonstrated that the homo-
zygote global Fstl1 knockout mice die at birth due to respira-
tory distress. Here, we generated a mouse line in which Fstl1
is conditionally impaired in endothelial and endothelial-
derived cells using Tie2-cre targeted gene deletion, which
will be referred to as Fstl1-eKO. Fstl1-eKO knockout pups
were born alive at the expected Mendelian ratio (25%).
However, 70% of Fstl1-eKO mice had died by three
weeks after birth whereas all their littermate controls,
Fstl1ﬂ/WT Tie2-cre, Fstl1KO/ﬂ, and Fstl1WT/ﬂ mice survived
(Fig. 1a). In contrast to Fstl1-KOmice, which display abnor-
mal tracheal cartilage formation and thickening of alveolar
septa, Fstl1-eKO mice had macroscopically normal tracheal
cartilage formation and normal alveolarization
(Supplementary Figure 1). In view of the postnatal lethality
of Fstl1-eKOmice and the marked diﬀerences with the global
Fstl1-KOmice, we quantiﬁed Fstl1 mRNA and protein in the
lungs of these animals. Fstl1 was highly expressed in the con-
trol mice at one week after birth and signiﬁcantly declined
three weeks after birth (mRNA P< 0.005; protein P< 0.05;
Fig. 1b and 1c), suggesting Fstl1 is crucial in the early stages
of postnatal lung development. The expression of Fstl1
mRNA and protein in lung homogenates of Fstl1-eKO
mice were signiﬁcantly reduced compared with age-matched
controls at one week after birth (mRNA P< 0.005; protein
P< 0.05; Fig. 1b and 1c), whereas at three weeks after birth
the expression of Fstl1 mRNA and protein were not signiﬁ-
cantly diﬀerent in Fstl1-eKO mice compared with age-
matched controls (Fig. 1b and 1c). In situ hybridization on
sections of control mice showed expression of Fstl1 mRNA
both in blood vessels and lung parenchyma at one week. At
three weeks after birth, the pattern of expression was not
diﬀerent, though the staining intensity was markedly less,
which is in line with the qPCR ﬁndings (Fig. 1d). In the
Fstl1-eKO mice, the expression pattern of Fstl1 mRNA was
similar to the control mice, except that Fstl1mRNA was not
or hardly detectable in the endothelium of the blood vessels
both at one and three weeks after birth (Fig. 1d).
Right ventricular output is reduced in Fstl1-eKO mice
To shed light on the cause of neonatal lethality of Fstl1-eKO
mice, we determined the physiological function of the pulmon-
ary vasculature using echocardiography. During normal
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postnatal development, a signiﬁcant increase in right ventricu-
lar output was observed at three weeks compared with one
week as shown by the pulmonary valve (PV) and velocity-time
integral (VTI) parameters (P< 0.05; Fig. 2a). A signiﬁcant
reduction in right ventricular output in Fstl1-eKO mice was
observed at three weeks compared with age-matched controls
(P< 0.05; Fig. 2a). Other physiological parameters, including
PV peak gradient, PV mean gradient, PV peak velocity, and





























































Fig. 1. Endothelial deletion of Fstl1 in mice is postnatally lethal. (a) Kaplan–Meijer survival curve of Fstl1-eKO mice compared with controls.
Approximately 70% of Fstl1-eKO mice died at three weeks after birth compared with controls. (b) Gene expression analysis of Fstl1 in lung
homogenates using real-time qPCR. Horizontal line represents the median of 16–30 mice per group. (c) Immunoblot analysis of Fstl1 protein in
lung homogenates. Data are expressed as means SEM of the ratio of Fstl1 protein corrected to -actin as a reference protein from four to nine
mice per group. (d) Representative images of Fstl1 in situ hybridization in lung tissue of Fstl1-eKO mice compared with controls. Red arrowheads
point to the absence or presence of Fstl1 probes. AW, airway; V, blood vessel. Each data point represents an individual animal. *P< 0.05;
**P< 0.01; ***P< 0.005 compared with the indicated group; ns¼ not significant.
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x108
Fig. 2. Right ventricular output is reduced in Fstl1-eKO mice. Pulmonary functions were measured using echocardiograph. (a) Pulmonary valve
(PV)-velocity time integral (VTI) was significantly decreased in Fstl1-eKO mice compared with age-matched controls. (b) PV peak gradient, (c) PV
mean gradient, (d) PV peak velocity, (e) PV mean velocity, and (f) the ratio of Pulmonary Acceleration Time (PAT) corrected by the pulmonary
ejection time (ET) in percentage were unaltered in Fstl1-eKO mice compared with age-matched controls. Data are expressed as the mean SEM
of 4–19 mice per group. (g) The right ventricle (RV) volume of Fstl1-eKO mice was unaltered compared with age-matched controls. A significant
increase in RV volume was observed in Fstl1-eKO mice at three weeks compared with one week after birth. Data are expressed as the
mean SEM of three mice per group. *P< 0.05; **P< 0.01; ***P< 0.005 compared with the indicated group. ns, not significant.
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PV mean velocity, were signiﬁcantly increased at three weeks
compared with one week after birth both in control and in
Fstl1-eKO mice (P< 0.05; Fig. 2b–e). No diﬀerences between
Fstl1-eKO mice and age-matched controls were observed for
these parameters (Fig. 2b–e). A validated non-invasive method
to asses pulmonary vascular resistance22,23 was performed by
measuring pulmonary acceleration time (PAT) corrected for
the pulmonary ejection time (ET). There was no signiﬁcant
diﬀerence in pulmonary vascular resistance during normal
postnatal lung development as reﬂected by the ratio of PAT/
ET in control mice at three weeks compared with one week
after birth (Fig. 2f). A signiﬁcant change was also not observed
between Fstl1-eKO mice compared with age-matched controls
either at one week or three weeks after birth (Fig. 2f).
Moreover, we evaluated the muscularization of the right ven-
tricle using myocardial marker TnI, as an indicative of right
ventricle hypertrophy by measuring the volume of the right
ventricle. There were no changes in the right ventricle
volume at three weeks compared with one week after birth
in the control mice (Fig. 2g). At three weeks, there was a
trend towards increased RV volume in Fstl1-eKO mice com-
pared with age-matched controls (Fig. 2g). A signiﬁcant
increase in RV volume was observed in Fstl1-eKO mice at
three weeks compared with one week after birth (P¼ 0.005;
Fig. 2g).
Pulmonary vascular remodeling in Fstl1-eKO mice
In view of these results, we examined the eﬀect of endothe-
lial deletion of Fstl1 on pulmonary vascular phenotypes and
quantiﬁed the morphological changes and actin content in
large and small pulmonary vessels. During normal develop-
ment, the thickness of the large muscular arteries was unal-
tered in lung tissue of control mice at three weeks compared
with one week after birth (Fig. 3a), whereas the actin con-
tent was reduced in large elastic (P< 0.005) and muscular
arteries (P< 0.005) in lung tissue of control mice at three
weeks compared with one week after birth (Fig. 3b and 3c).
In Fstl1-eKO mice, the thickness and the actin content in
large muscular arteries were unaltered at three weeks com-
pared with one week after birth (Fig. 3a and 3c), whereas the
actin content in large elastic arteries was signiﬁcantly
reduced at three weeks compared with one week after
birth (P< 0.005; Fig. 3b). No signiﬁcant diﬀerences were
observed in the thickness of the large muscular arteries
(Fig. 3a) and in the actin content in large elastic and mus-
cular arteries in lung tissue of Fstl1-eKO mice compared
with age-matched controls at either one or three weeks
after birth (Fig. 3b and 3c). Reduction in actin content at
three weeks after birth seems to be limited to vascular
smooth muscle as there were no temporal changes in the
actin content in the airway smooth muscle bundles and
there was no observed diﬀerence between Fstl1-eKO mice
compared with age-matched controls (Fig. 3d).
We also explored the number of small blood vessels in
lung tissue as these may contribute to an important extent to
changes in pulmonary blood pressure. In normal develop-
ment, no signiﬁcant temporal change in the CD31 positive
total number of vessels was observed, whereas the percent-
age of actin-positive vessels was signiﬁcantly reduced at
three weeks compared with one week after birth (P< 0.01;
Fig. 3e and 3f). Although the CD31 positive total number of
vessels was not signiﬁcantly diﬀerent between Fstl1-eKO
mice compared with age-matched controls (Fig. 3e), the per-
centage of actin-positive small pulmonary vessels was sig-
niﬁcantly higher in Fstl1-eKO mice at three weeks after birth
compared with age-matched controls (P< 0.05; Fig. 3f).
Increased BMP/Smad signaling in the lung
of Fstl1-eKO mice
To unravel whether endothelial Fstl1 modulates BMP sig-
naling during postnatal development, we investigated the
activity of BMP/Smad signaling in lung homogenates
using pSmad1/5/8 antibodies. During normal postnatal
development, Smad1/5/8 phosphorylation was higher at
three weeks compared with one week after birth (P< 0.05;
Fig. 4a). In addition, we found increased levels of pSmad1/
5/8 in lung homogenates of Fstl1-eKO compared with age-
matched controls at one week after birth (P< 0.05; Fig. 4a),
whereas, the level of pSmad1/5/8 at three weeks was unal-
tered in Fstl1-eKO mice compared with age-matched con-
trols (Fig. 4a).
To study the role of BMP signaling further, we selected
previously identiﬁed pSmad1/5/8 target genes which relate
to vascular remodelling:24 Id3, Epas1, Zeb2, Zfp423, Ephb4,
Klf4, Flt1, Jag1, Eng, Gata2, Vegf. Of these, we found that
the expression of Jagged1, Endoglin, and Gata2 was altered
in Fstl1-eKO mice compared with age-matched controls
with a nominal P value< 0.05, whereas the expression
level of the other genes was not diﬀerent. Therefore,
Jagged1, Endoglin, and Gata2 were included for further
analysis. Consistent with the increased Smad1/5/8 activa-
tion, Jagged1 and Endoglin mRNA and protein were
increased in lung tissue of control mice at three weeks com-
pared with one week after birth (Jagged1 mRNA P< 0.05;
protein P< 0.05; Fig. 4b and 4d; Endoglin protein P< 0.01;
Fig. 4c and 4e). In line with increased phosphorylation of
Smad1/5/8, the expression of Jagged1 and Endoglin mRNA
and protein was also increased in lung homogenates of one
week Fstl1-eKO mice compared with age-matched controls
(Jagged1 mRNA P< 0.05; protein P< 0.05; Fig. 4b and 4d;
Endoglin mRNA P< 0.05; protein P< 0.01; Fig. 4c and 4e).
At three weeks, Jagged1 mRNA (P< 0.01) and protein
(P< 0.05) were reduced in the Fstl1-eKO mice compared
with age-matched controls (Fig. 4b and 4d), whereas
Endoglin was not diﬀerent compared with age-matched con-
trols (Fig. 4c and 4e).
The mRNA expression of the transcription factor Gata2
was higher in the lung homogenates of control mice at three
weeks compared with one week after birth (P< 0.01;
Fig. 5a). Accordingly, the level of mRNA and protein
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Fig. 3. Number of actin-positive small pulmonary vessels is increased in the lung tissue of Fstl1-eKO mice at three weeks. (a) The thickness of
large muscular arteries in lung tissue was quantified and expressed as ratio of total area of tunica media over the square of the length of the tunica
intima. Horizontal lines represent the median of n¼ 9–16 vessels from N¼ 6–8 mice per group. (b) The a-SMA content in large elastic arteries
and (c) in large muscular arteries in lung tissue was quantified and expressed as ratio of the actin-positive area over the square of the length of
tunica intima. Horizontal lines represent the median of n¼ 9–26 vessels per group from N¼ 5–12 mice per group. (d) The a-SMA content in
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expression of the Gata2 target gene Endothelin-1, a potent
vasoconstrictor, was also increased in lung homogenates of
control mice at three weeks compared with one week after
birth (mRNA P< 0.005; protein P< 0.05; Fig. 5b and 5c).
Gata2 mRNA and Endothelin-1 mRNA and protein levels
were increased in lung homogenates of Fstl1-eKO mice com-
pared with age-matched controls at one week after birth
(Endothelin-1 mRNA P< 0.05; protein P< 0.01; Fig. 5b
and 5c). These levels did not further increase at three
weeks after birth and were no longer diﬀerent compared
with age-matched controls (Fig. 5a–c).
Discussion
Proper formation and maturation of the pulmonary vascu-
lature is essential to support normal lung development and
function.25 BMP signaling is crucial in dynamic processes of
vessel growth and vessel maturation.9,12,26–29 Maturation of
immature vessels proceeds according to the developmental
steps: (1) stabilization of the immature vessels; (2) vessel
branching, remodeling, and pruning; and (3) vessel special-
ization.30 Deregulation of molecules involved in vessel
growth and maturation leads to vascular abnormalities
and dysfunction.
In this study, the role of endothelial Fstl1 in postnatal
maturation of the pulmonary vasculature was investigated
in vivo using Tie2-cre targeted endothelial-speciﬁc deletion.
Conditional deletion of Fstl1 from endothelium was post-
natally lethal, and resulted in small pulmonary vessel
changes, pointing to a critical role of endothelial Fstl1 in
postnatal lung development. In line with the idea that Fstl1
is a BMP antagonist, phosphorylation of BMP/Smad sig-
naling showed the inverse pattern of Fstl1 expression level
during normal postnatal development. In the early stages of
postnatal development, high Fstl1 expression is associated
with low phosphorylated Smad1/5/8 at one week after birth
whereas at later stages of postnatal development, decreased
in Fstl1 expression is associated with increased phosphoryl-
ation of BMP/Smad signaling in lung tissue of control mice.
We also demonstrate that during early stages of postnatal
development, high Fstl1 expression coincides with high actin
content in the large muscular and elastic arteries and high
percentage of actin-positive small pulmonary vessels in lung
tissue of control mice. In later stages of postnatal develop-
ment, low Fstl1 expression coexists with low actin content in
the large muscular and elastic arteries and low percentage of
actin-positive small pulmonary vessels in lung tissue of con-
trol mice. Recently, it was reported that Fstl1 mediates
TGF--induced a-SMA expression by antagonizing BMP
signaling in lung ﬁbroblasts.31 We speculate that Fstl1
antagonizes BMP signaling to facilitate TGF--induced
a-SMA expression from vascular smooth muscle cells in
the early stages of normal vascular development. Reduced
Fstl1 levels in later stages of development in turn result in
reduction in actin content, suggesting that Fstl1 possibly
mediates endothelial-mural cell communication by modulat-
ing BMP/TGF- signaling during normal pulmonary vascu-
lar development.
During normal postnatal vascular development, transient
reduction of actin content in pulmonary vessels is normal
and an indication of maturation of pulmonary vessels by
reducing contractility of pulmonary arteries.32 Our data
indicate that loss of Fstl1 in endothelium prevents this
normal reduction of actin in small pulmonary vessels and
as such delays pulmonary vascular maturation.
Mechanistically, Fstl1-eKO mice have increased Smad1/
5/8 phosphorylation and expression of pSmad1/5/8-regu-
lated genes in the lung, including Gata2, Endoglin, and
Jagged1. Previous studies demonstrated the important role
of Jagged1 and Endoglin in vascular specialization and vas-
cular remodeling, respectively, in the later stages of vessel
maturation.10,33,34 In the early stages of normal develop-
ment, high levels of Fstl1 inhibit BMP signaling and its
regulated genes, Gata2, Jagged1, and Endoglin, indicating
that modulation of BMP signaling by Fstl1 is important in
early stages of postnatal lung development. On the other
hand, low levels of Fstl1 in later stages of development
lead to increased BMP-mediated Smad phosphorylation
and its regulated genes Gata2, Jagged1, and Endoglin.
Endoglin is a type III TGF- receptor which is predomin-
antly expressed in proliferating endothelial cells and triggers
endothelial cell proliferation and vascular remodeling.34–37
The importance of Endoglin for normal vascular formation
and homeostasis is evident in Endoglin null (Eng–/–) mice,
which exhibit vascular deformities.37–40 Increased Endoglin
expression in Fstl1-eKO mice at the early stages of postnatal
pulmonary vascular development might shift the balance
towards endothelial cell migration and proliferation instead
of maturation. This supports the contention that Fstl1-eKO
mice have delayed pulmonary vascular maturation.
The Notch ligand Jagged1 is an important regulator
of cell fate in embryonic development41 and vessel fate in
Fig. 3. Continued
airway smooth muscle bundles surrounding the airway in lung tissue was quantified and expressed as ratio of the actin-positive area over the
square of the length of basement membrane. Horizontal lines represent the median of n¼ 9–34 vessels per group from N¼ 5–13 mice per group.
(e) Total number of vessels in lung tissue was quantified using CD31 staining and expressed as ratio of total vessel number/lung surface area (cm2).
Horizontal lines represent the median of the vessel number/cm2 of N¼ 7–12 mice per group. (f) The percentage of actin-positive small
pulmonary vessels in lung tissue was quantified and expressed as percentage of actin-positive small vessel number/total vessel number. Horizontal
lines represent the median of the percentage of actin-positive vessels of N¼ 7–12 mice per group. Representative images of tissue sections taken
at three weeks after birth were shown. AW, airway; V, blood vessel. Scale bars represent 100 mm. Magnification 200. *P< 0.05; **P< 0.01;
***P< 0.005 compared with the indicated group.
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Fig. 4. Increased activation of Smad1/5/8 and Smad1/5/8-regulated genes in the lung of Fstl1-eKO mice. (a) Immunoblot analysis of pSmad1/5/8 in
lung homogenates. Data are expressed as means SEM of the ratios of pSmad1/5/8 corrected to total Smad1 of four to nine mice per group.
Pulmonary expression of the pSmad1/5/8-regulated genes, Jagged1 (b) and Endoglin (c) in lung homogenates. Data are expressed as starting
concentration N0 in arbitrary units corrected to B2m and Hprt as reference genes. Horizontal lines represent medians of 11–30 mice per group.
(d) Immunoblot of Jagged1 protein in lung homogenates and its quantification. Data are expressed as means SEM of the ratios of Jagged1 over
the reference protein -actin of four to nine mice per group. (d) Immunoblot of Endoglin in lung homogenates and its quantification. Data are
expressed as means SEM of the ratios of Endoglin over the reference protein -actin of four to nine mice per group. *P< 0.05; **P< 0.01;
***P< 0.005 compared with the indicated group.
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pulmonary vascular maturation.10,33 In addition, it has a
signiﬁcant role in angiogenesis and vascular homeosta-
sis.42,43 Ablation of Jagged1 in mice is embryonically
lethal and leads to vascular abnormalities and defects in
vascular remodeling.33 The aberrant Jagged1 expression
during early stages of postnatal pulmonary vascular devel-
opment in Fstl1-eKO mice might lead to deregulation of
vascular remodeling and disruption of the vessel specializa-
tion programs.
BMP/Smad increases expression of the transcription
factor Gata2, subsequently promoting the expression
of the most potent vasoconstrictor Endothelin-1.44–46 We
demonstrate that Endothelin-1 levels are low at the early
stages of normal development and increase at the later
stages of normal development. We found that endothelial
deletion of Fstl1 is associated with increased Endothelin-1
mRNA and protein expression at the early stages of devel-
opment in the lung. Increased Endothelin-1 has been
reported to promote proliferation and migration of endo-
thelial cells and contribute to increased pulmonary vascular
resistance and subsequent right ventricle hypertrophy,47,48
suggesting pivotal roles of Endothelin-1 in vessel formation,
vascular remodeling, and vascular tone maintenance. Our
data suggest that Endothelin-1 expression is negatively regu-
lated by Fstl1 via inhibiting Smad1/5/8 and the Gata2 tran-
scription factor, presumably by antagonizing BMP
signaling. These ﬁndings are in line with previous studies
demonstrating that Endothelin-1 expression is regulated by
BMP via Smad1/5/8 in endothelial cells.44–46
Lower right ventricular output and small vascular
remodeling were visible at three weeks after birth, whereas
elevation in BMP/Smad phosphorylation and of its down-
stream targets Jagged1, Endoglin, Gata2, and Endothelin-1
were more prominent at one week after birth in Fstl1-eKO
mice, indicating that molecular changes are more transient
than their physiological and morphological consequences.
As a consequence, the functional and morphological diﬀer-
ences seen at three weeks after birth were initiated earlier
during postnatal development. Alternatively, the activation
of BMP/Smad signaling alone may not be suﬃcient to aﬀect
the pulmonary vasculature structurally and functionally at
early stages of development, but instead becomes evident at
a later time point. Despite of higher percentages of actin-
positive small pulmonary vessels and notably decreased
right ventricular output, there were minimum morpho-
logical defects of large pulmonary vessels, normal pulmon-
ary vascular resistance as reﬂected by the ratio of PAT/ET
in Fstl1-eKO mice, and a trend towards right ventricle
hypertrophy. This may suggest very early stages of pulmon-
ary vascular dysfunction in Fstl1-eKO mice. This phenotype
is also commonly observed in patients with PAH, in which
molecular changes/defects in BMP signaling manifest early
in the disease followed by physiological and structural
changes which are observed at later stages of the disease
progression.49 In addition, our data may imply that the
molecular and morphological changes in the lung are





































































Fig. 5. Increased Endothelin-1 in the lung of Fstl1-eKO mice. (a)
Pulmonary mRNA expression of Gata2 transcription factor and (b)
Endothelin-1 in the lung homogenates. Data are expressed as starting
concentration N0 in arbitrary units corrected to B2m and Hprt as
reference genes. (c) Endothelin-1 protein concentration in lung hom-
ogenates is expressed as Endothelin-1 concentration in pg/ml per 1 mg
protein lysates. Each data points represent an individual animal.
Horizontal line represents the median of Endothelin-1 concentration
of 8–12 mice per group. *P< 0.05; **P< 0.01; ***P< 0.005 compared
with the indicated group.
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possibly a secondary consequence of the right heart dysfunc-
tion as reﬂected by reduction in RV output. The morpho-
logical and physiological functions of the heart of Fstl1-eKO
mice are currently under investigation.
In conclusion, our ﬁndings demonstrate that loss of endo-
thelial Fstl1 in the lung is associated with increased BMP/
Smad phosphorylation and elevations in its downstream
targets Jagged1, Endoglin, Gata2, and Endothelin-1. These
changes are associated with impaired small pulmonary vas-
cular remodeling and decreased right ventricular output.
Taken together, our ﬁndings suggest a key role of Fstl1 in
titrating the level of BMP signaling for proper postnatal
lung development.
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